Cor Vasa 2009, 51(10):717-719 | DOI: 10.33678/cor.2009.175
The effect of the "CorCap Cardiac Support Device" on left ventricular remodeling: one-year follow-up of the first IKEM patient
- 1 Klinika kardiovaskulární chirurgie
- 2 Klinika anesteziologie a resuscitace, Institut klinické a experimentální medicíny
- 3 Centrum výzkumu srdce a cév, Praha, Česká republika
Surgical intervention is an option for treating the remodeled and dilated left ventricle of the patient with heart failure. The CorCap cardiac support device (CSD) is a mesh fabric device that is implanted around the heart and presents a new option in the surgical treatment of the failing heart. The objective of this case report was to introduce the method and to evaluate the effect of implantation of CorCap CSD in the first patient at the Institute for Clinical and Experimental Medicine (shortly IKEM in Czech). The patient (64 years old) with dilated cardiomyopathy, in NYHA class III and with significant mitral regurgitation, was treated with annuloplasty of the mitral valve and CorCap CSD implantation. Left ventricular ejection fraction, diameters and volumes, and dP/dt were measured by echo-cardiography during the first year after operation. Our combined procedure led to a marked decrease in left ventricular end-diastolic and end-systolic volumes, left ventricular diameter, increase in ejection fraction and improvement of dP/dt. Quality of life and NYHA functional class were also improved. We can conclude that CorCap CSD implantation together with mitral valve surgery has a long-term beneficial impact on left ventricular size and function of the failing heart, and physicians should consider offering this combined procedure to patients with heart failure.
Keywords: Heart failure; Surgical management; Implantable cardiac support devices
Published: October 1, 2009 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Cohn JN. Structural basis for heart failure. Ventricular remodeling and its pharmacological inhibition. Circulation 1995;91:2504-7.
Go to original source...
- Lee TH, Hamilton MA, Stevenson LW, et al. Am J Cardiol 1993;72:672-6.
Go to original source...
- Oz MC, Konertz WF, Kleber FX, et al. Global surgical experience with the Acorn cardiac support device. J Thorac Cardiovasc Surg 2003;126:983-91.
Go to original source...
- Mann DL, Acker MA, Jessup M, et al. Acorn Trial Principal Investigators and Study Coordinators. Clinical evaluation of the CorCap Cardiac Support Device in patients with dilated cardiomyopathy. Ann Thorac Surg 2007;84: 1226-35.
Go to original source...
Go to PubMed...
- Starling RC, Jessup M, Oh JK, et al. Sustained benefits of the CorCap Cardiac Support Device on left ventricular remodeling: three year follow-up results from the Acorn clinical trial. Ann Thorac Surg 2007;84:1236-42.
Go to original source...
Go to PubMed...
- Koelling TM, Aaronson KD, Cody RJ, Bach DS, Armstrong WF. Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J 2002;144:524-9.
Go to original source...
Go to PubMed...
- Acker MA, Bolling S, Shemin R, et al. Acorn Trial Principal Investigators and Study Coordinators. Mitral valve surgery in heart failure: insights from the Acorn Clinical Trial. J Thorac Cardiovasc Surg 2006;132:568-77.
Go to original source...
Go to PubMed...